Fus3 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Fus3, a mitogen-activated protein kinase (MAPK) found in yeast cells, particularly in *Saccharomyces cerevisiae*. Fus3 plays a central role in the mating pheromone response pathway, mediating signal transduction involved in the cellular processes of growth, differentiation, and response to external signals. The inhibition of Fus3 disrupts its ability to phosphorylate downstream targets, which is crucial for the regulation of gene expression and cell cycle progression associated with mating. By blocking Fus3 activity, these inhibitors can affect the cell's ability to undergo processes such as mating projection formation and cell cycle arrest.
At the molecular level, Fus3 inhibitors typically function by binding to the active site of the kinase, preventing the phosphorylation of its substrates. This results in the inhibition of the signaling cascade that Fus3 normally drives, leading to the modulation of cellular responses controlled by the pheromone signaling pathway. These compounds may show structural diversity, often designed to fit into the ATP-binding pocket of Fus3, thereby competitively or non-competitively inhibiting its activity. As MAPK signaling pathways are highly conserved across species, the study of Fus3 inhibitors also provides insights into broader kinase regulation and MAPK signaling in other organisms. Understanding the specificity and mechanism of these inhibitors is crucial for exploring the fundamental biology of cell signaling, mating behavior in yeast, and the regulation of MAPK cascades.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor, potentially affecting MAPK pathways analogous to the one involving Fus3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, potentially affecting MAPK pathways related to Fus3's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which could indirectly impact Fus3 by modulating stress-activated MAPK pathways. | ||||||
Doramapimod | 285983-48-4 | sc-300502 sc-300502A sc-300502B | 25 mg 50 mg 100 mg | $149.00 $281.00 $459.00 | 2 | |
BIRB 796 is a potent p38 MAPK inhibitor, which might have indirect effects on MAPK pathways involving Fus3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which may influence various signaling pathways, potentially impacting Fus3 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can modulate several cellular processes, potentially influencing Fus3 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which might indirectly affect Fus3 through its role in cell signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, potentially impacting Fus3 activity among other kinases. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin is an adenosine kinase inhibitor, which may have indirect effects on Fus3 and related pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a kinase inhibitor, might indirectly influence Fus3 activity by targeting related kinases. | ||||||